baber/WOPTO huggingface dataset:
Patent DE-69027211-D1 (DE)
Inventor: URDEA MICHAEL
IPC: C12Q1/68
Filed: 1990-04-16
Granted: 1996-07-04
Abstract: Linear or branched oligonucleotide multimers useful as amplifiers in biochemical assays which comprise (1) at least one first single-stranded oligonucleotide unit that is complementary to a single-stranded oligonucleotide sequence of interest, and (2) a multiplicity of second single-stranded oligonucleotide units that are complementary to a single-stranded labeled oligonucleotide. Amplified sandwich nucleic acid hybridizations and immunoassays using the multimers are exemplified.
Patent DE-69033881-D1 (DE)
Inventor: GERSTENBERG THOMAS
IPC: A61K38/095
Filed: 1990-09-14
Granted: 2002-01-31
Abstract: The present invention provides methods and compositions for inducing penile erections, sufficient for vaginal penetration, in a human male suffering from impotence. When the impotence is substantially only neurogenic, psycogenic or neurogenic and psychogenic, a method of the invention comprises (A) administering to the male by intracavernosal injection peptide N-terminal histidine C-terminal methionineamide and (B) sexually stimulating the male. When the impotence is caused by severe atherosclerosis, a method of the invention comprises (A) administering to the male by intracavernosal injection an amount of a physiologically acceptable composition comprising (1) a neuropeptide selected from the group consisting of human vasoactive intestinal peptide and peptide N-terminal histidine C-terminal methionineamide and (2) an alpha-adrenergic blocker, such as phentolamine or prazosin, and (B) sexually stimulating the male. The invention also entails a physiologically acceptable composition suitable for use in inducing, upon administration by intracavernosal injection, an erection, sufficient for vaginal penetration, in a human male suffering from impotence, which is caused by severe atherosclerosis, which composition comprises (1) a neuropeptide selected from the group consisting of vasoactive intestinal peptide and peptide N-terminal histidine C-terminal methionineamide and (2) an alpha-adrenergic blocker, such as phentolamine or prazosin.
Patent DE-69106521-D1 (DE)
Inventor: ANKER LISBETH
IPC: C12N9/42
Filed: 1991-08-23
Granted: 1995-02-16
Abstract: This invention relates to novel enzymes possessing xylanolytic activity. More specifically, the invention relates to novel xylanases obtainable from strains of Bacillus pumilus, a process for their preparation, and the use of these xylanases for treatment of lignocellulosic pulp.
Patent DE-69107940-D1 (DE)
Inventor: ELSBY LEIF
IPC: D21H11/10
Filed: 1991-09-10
Granted: 1995-04-13
Abstract: A paper having an advantageous combination of softness and strength is disclosed, which is based on a mixture of cellulosic pulps and in which   a) 55-90% by weight, of the total amount of cellulose fibres consists of a hardwood pulp, a waste paper pulp or a mechanical or semi-mechanical cellulosic pulp, or a mixture thereof, having a drainage resistance below 25<0>SR, and b) 10-45% by weight, of the total amount of cellulose fibres consists of a sulphite pulp and/or sulphate pulp based on softwood and having a drainage resistance exceeding 30<0>SR.   The paper can be produced by preparing a stock from the cellulosic pulps a) and b) in the above amounts, whereupon the stock is taken up on a wire, and is drained and dried in per se known manner.
Patent DE-69112554-D1 (DE)
Inventor: WILLIAMS ERNEST DONALD
IPC: B65D81/113
Filed: 1991-09-05
Granted: 1995-10-05
Abstract: An article protector, such as may be used to protect bottles during transportation, is assembled from a plurality of interfitting parts (8, 10: 40, 42); which may be interfitted to provide an open framework within which a bottle may be supported and securely held for protection, the members are produced by being stamped from cellular plastics material providing in sheet or slab form. The interfitting members may be permanently secured together to provide to superstructures (10) which may be located together around the articles to be protected, being secured together by releasable securing means or may be provided y members (40, 42; 140, 142) which are retained in an enclosing condition by virtue of being located within a carton. <IMAGE>
Patent DE-69117886-D1 (DE)
Inventor: GYSLER CHRISTOF
IPC: A21D8/04
Filed: 1991-10-14
Granted: 1996-04-18
Abstract: Strains of Saccharomyces cerevisiae are substantially inactive at refrigeration temperatures of 3 DEG  C. to 9-10 DEG  C. and recover their activity at temperatures of 13 DEG -14 DEG  C.
Patent DE-69118566-D1 (DE)
Inventor: LEVIEN RAPHAEL L
IPC: H04N1/48
Filed: 1991-02-06
Granted: 1996-05-15
Abstract: Tone values of a photographic image are stored in a frame store (20) and retrieved from the frame store to produce a corresponding video display. A mouse (17) or trackball is used to locate a point on display and a gamma correction curve look up table (22R,22G,22B) is used to interactively show the effect of color correction. Adjustment can be made via lighter and darker switches (14,15) on the mouse or trackball. These switches subtract or add a bump function to the gamma correction curve in the selected color density plane. The bump function is displaced by the measured tone value in order to achieve more flexible control over the color correction. <IMAGE>   <IMAGE>
Patent DE-69121495-D1 (DE)
Inventor: CAMPBELL WILLIAM PATRICK
IPC: A61M5/32
Filed: 1991-03-18
Granted: 1996-09-26
Abstract: Disclosed is a hypodermic injection device wherein the needle can be retracted into the reservoir chamber, after use, for disposal. The device includes a plunger having a needle-retention chamber in the end of the plunger closest to the needle structure. The end portion of the needle can be resilient, and shaped, such that the end of the needle can be retained in the needle-retention chamber when the plunger reaches the end of its stroke toward the needle. Other structures for ensuring retention of the needle is the needle-retention chamber are also disclosed. Also disclosed is structure for ensuring that the needle cannot be relocated for re-use, once it has been withdrawn into the reservoir chamber, and structure avoiding accidental retention of the needle in the needle-retention chamber.
Patent DE-69125976-D1 (DE)
Inventor: HANSCOMBE PAUL ANTHONY
IPC: G01K11/22
Filed: 1991-06-13
Granted: 1997-06-12
Abstract: A distributed temperature sensor comprises an elongate ultrasonic waveguide having a number of zones along its length, each zone having a grating formed in it. This is typically achieved by incorporating uniformly spaced notches or bands (or collars) throughout the zone. The grating spacing in each zone is different, so that each grating reflects a characteristic frequency. This frequency varies as the temperature of the zone varies, so if wide-band ultrasonic pulses are launched into the waveguide, the temperature of each zone can be determined from the reflected frequencies.
Patent DE-69128340-D1 (DE)
Inventor: TERAUCHI MICHIYOSHI
IPC: E03F3/04
Filed: 1991-09-03
Granted: 1998-01-15
Abstract: The invention relates to a seal (1) for a joint comprising a cylindrical inner core layer (2) made of a water-unexpansible flexible material and having an internal opening (2a), and an outer coating layer (3) which is made of a water-expansible rubber. The outer coating layer (3) coats the inner core layer (2) and has penetrating openings (4) in the form of slits, pinholes or the like. The penetrating openings (4) extend to penetrating openings in the inner core layer (2) and communicate with the internal opening (2a) through the penetrating openings of the inner core layer (2). <IMAGE>
Patent DE-69211334-D1 (DE)
Inventor: GUTH CHRISTIAN
IPC: C09K23/42
Filed: 1992-02-12
Granted: 1996-07-11
Abstract: There is described a low-foaming, nonsilicone, aqueous textile auxiliary composition comprising (a) a homopolymer of an ethylenically unsaturated sulfonic or carboxylic acid or an anhydride thereof, (b) a nonionic surfactant of formula   <IMAGE>   wherein R is an aliphatic radical of at least 8 carbon atoms, R1 is hydrogen, C1-C8alkyl, a cycloaliphatic radical of at least 5 carbon atoms, styryl, an unsubstituted or halogen substituted C1-C10alkylisocyanato or an unsubstituted or by a hetero atom substituted cycloalkylisocyanato or cycloalkenylisocyanato radical, "alkylene" denotes an alkylene radical of 2 to 4 carbon atoms, and p is an integer from 2 to 60, and optionally (c) a hydrotropic agent. The textile auxiliary composition is suitable for use as dispersants and for wetting, washing and/or bleaching fiber materials.
Patent DE-69215088-D1 (DE)
Title: Filter
Inventor: VAN T OOSTEN JAMES
IPC: F24F8/158
Filed: 1992-05-14
Granted: 1996-12-12
Abstract: A chemisorptive filter e.g. activated alumina or carbon, is held in a chamber (16) between two webs of expanded metal mesh (5, 6) provided with angled perforations. The webs are rigidified in the direction of air flow (4) by a central post joining them. This filter is provided with prefiltering by a mechanical filter layer (19), e.g. polyester polyurethane foam and a layer with both electret and electrostatic activity (21). The chamber (16) may be provided with a window so that any colour change indicative of the remaining capacity of the chemisorptive material can be seen.
Patent DE-69219072-D1 (DE)
Inventor: PAUL DIDIER
IPC: C23G1/08
Filed: 1992-11-05
Granted: 1997-05-22
Abstract: Process for pickling steel materials, especially continuously on a processing line, comprising a shot-blasting operation, a preparing operation, a pickling operation and a passivating operation, in which the preparing operation is carried out by placing the materials in contact with at least one 2-10N sulphuric acid solution, and in which the pickling operation is carried out by placing the materials in contact with at least one solution containing 1 to 10 % by weight of hydrofluoric acid, Fe<2+> and Fe<3+> ions.
Patent DE-69224131-D1 (DE)
Inventor: DUNN RICHARD L
IPC: A61K39/00
Filed: 1992-10-01
Granted: 1998-02-26
Abstract: The invention is directed to an improved system for controlled release of biologically active materials and to a liquid composition for its formation. The liquid composition is composed of a thermoplastic polymer, rate modifying agent, bioactive material and organic solvent. The liquid composition is capable of forming a biodegradable and/or bioerodible microporous, solid polymer matrix. The matrix is useful as an implant in patients (humans and animals) for delivery of biologically active substances to tissues or organs.
Patent DE-69301179-D1 (DE)
Inventor: RICA LINDA
IPC: A61Q1/06
Filed: 1993-03-31
Granted: 1996-02-15
Abstract: Composition de rouge à lèvres comprenant des sphères d'un copolymère de polyvinylidène qui présente un aspect mat et une texture homogène et légère. L'emploi de sphères d'un copolymère de polyvinylidène en tant qu'agent matifiant, permet d'incorporer dans la composition de rouge à lèvres des quantités plus importantes de substances de nature émolliente sans pour autant aboutir à un effet brillant indésirable.
Patent DE-69301307-D1 (DE)
Inventor: VILNES DAG
IPC: G09F9/00
Filed: 1993-02-05
Granted: 1996-02-22
Abstract: PCT No. PCT/NO93/00022 Sec. 371 Date Aug. 2, 1994 Sec. 102(e) Date Aug. 2, 1994 PCT Filed Feb. 5, 1993 PCT Pub. No. WO93/16578 PCT Pub. Date Aug. 19, 1993.A method for installing or removing modules of elements in a panel structure, especially for installing display modules in a large screen, the modules are mounted in a lattice formed by orthogonally crossing chords which can be moved in a horizontal and vertical direction in a frame structure in which the chords are fitted. A panel structure wherein the method is used, consists of a lattice of orthogonally crossing chords fitted in a frame structure in which a carrier device consisting of movable sections is arranged to give the chords a horizontal or vertical displacement.
Patent DE-69324302-D1 (DE)
Inventor: BRYSON NATHAN
IPC: C08K5/00
Filed: 1993-01-14
Granted: 1999-05-12
Abstract: PCT No. PCT/FR93/00040 Sec. 371 Date Nov. 2, 1993 Sec. 102(e) Date Nov. 2, 1993 PCT Filed Jan. 14, 1993 PCT Pub. No. WO93/14164 PCT Pub. Date Jul. 22, 1993The subject-matter of the present invention is to solve the technical problem resulting from the instability in air of polysilanes. For this purpose, it proposes a polysilane-based composition, used particularly for producing silicon carbide, comprising: polysilane chains capable of being degraded by oxidation and the formation of polysiloxane-type products and/or polysilane chains suitable for being bound together directly by a reaction between Si-H and Si-X radicals, and/or indirectly through the intermediary of a crosslinking additive and by a reaction between A-X and A-H radicals, X being an olefin radical, preferably comprising 1 to 18 carbon atoms and, more preferably still, being constituted by a vinyl radical (Vi:-CH=CH2), A being an organic, organosilicic or silicic radical; and at least one antioxidant system.
Patent DE-69334189-D1 (DE)
Inventor: FOOTE JAMES B
IPC: H01L31/073
Filed: 1993-05-06
Granted: 2008-01-17
Abstract: A method for making a large area photovoltaic device (22) that is capable of generating low cost electrical power. The method involves depositing a layer of cadmium telluride onto an upwardly facing surface of a substrate and depositing an additional semiconductor material as a separate layer. The semiconductor interfaces the cadmium telluride such that an electrical junction can be formed.
Patent DE-69405425-D1 (DE)
Inventor: SOHDA TAKASHI
IPC: C07D498/04
Filed: 1994-02-25
Granted: 1997-10-16
Abstract: Novel 2,4-Oxazolidinedione compounds of the formula (I): <CHEM> wherein R is an hydrocarbon residue or an heterocyclic group, each of which may independently be substituted; Y is -CO-, -CH(OH) or -NR<3>- (wherein R<3> is an alkyl group, which may itself be substituted); m is O or 1; n is 0, 1 or 2; X is CH or N; A is a bivalent straight or branched chain hydrocarbon residue having 1 to 7 carbon atoms; R<1> and R<2> are each independently hydrogen or an alkyl group, or R<1> and R<2> combine with each other to form a 5- to 6-membered heterocyclic group, optionally containing nitrogen; L and M are each hydrogen, or L and M combine with each other to form a bond; and     pharmaceutically acceptable salts thereof, have excellent hypoglycemic and hypolipidemic activities, and are useful as antidiabetics or as hypolipidemic agents.
Patent DE-69422798-D1 (DE)
Inventor: BITOWFT BRUCE KEVIN
IPC: B65D43/24
Filed: 1994-05-04
Granted: 2000-03-02
Abstract: The invention relates to a container (1) for containing a stack of moist wipes (7). The container comprises a container body (5) and a lid (3) covering the container body. A dispensing aperture (15) in the lid (3) is covered by a hinging cover (9). Retention means (13) are provided for keeping the cover (9) in a first opened position in which the cover is pivoted around its hinging axis by less than 180<o>, preferably less than 135 <o>, upon exertion of a predetermined force on the cover. The retention means prevent the cover from falling or bouncing back into its closed position after having been opened. The retention means are configured such that the cover is further hingeable from its first open position to a second open position by exertion of a second predetermined force on the lid. This prevents that the container is toppled over when too large a force is exerted on the lid, or that the lid is accidentally broken off from the container. <IMAGE>
Patent DE-69426372-D1 (DE)
Inventor: ORJAVES-VENERO AURELIO
IPC: C07D235/30
Filed: 1994-05-19
Granted: 2001-01-11
Abstract: New 1-phenylmethyl benzimidazole piperazine derivatives of general formula <CHEM> are described wherein R<1> and R<2> can be a hydrogen atom, a halogen atom, a short chain alkyl group, a nitro group, and a hydroxy group, and their addition salts with pharmaceutically acceptable acids. These compounds have pharmacological activity as serotonin 5HT3 receptor antagonists.
Patent DE-69429721-D1 (DE)
Inventor: MAJOR EUGENE O
IPC: A61K35/30
Filed: 1994-04-11
Granted: 2002-03-14
Abstract: Human fetal neuro-derived cell lines are implanted into host tissues. The methods allow for treatment of a variety of neurological disorders and other diseases. A preferred cell line is SVG.
Patent DE-69501778-D1 (DE)
Inventor: STARR RONALD N
IPC: H02G3/20
Filed: 1995-10-25
Granted: 1998-04-16
Abstract: A modular lighting display system having an outlet track is provided. The outlet track includes a pair of sidewalls and a dividing wall having a first terminal end and a second terminal end. The dividing wall is located between the pair of sidewalls and extends from the first terminal end to the second terminal end of the outlet track. The dividing wall thereby defines a raceway portion and an outlet portion. The raceway portion and the outlet portion each have an open section. Electrical outlets are disposed along a length of the outlet portion of the outlet track. A pair of rails constructed and arranged at the open section of both the raceway portion and the outlet portion is provided. The modular lighting display system also has a fixture display bracket having at least one mounting tab constructed to span the open section of the outlet portion so that the bracket is supported on the pair of rails at the open section of the outlet portion. The fixture display bracket is capable of carrying a number of different fixtures and also has an individual power cord. <IMAGE>
Patent DE-69502153-D1 (DE)
Inventor: KJELL DOUGLAS PATTON
IPC: C07C/
Filed: 1995-08-30
Granted: 1998-05-28
Abstract: The present invention provides a novel process for preparing a compound of formula I <CHEM>  wherein     R is C1-C4 alkyl; R<1> and R<2> each are independently C1-C4 alkyl, or combine to form piperidinyl, pyrrolidinyl, methylpyrrolidino, dimethylpyrrolidino, morpholino, dimethylamino, diethylamino, or 1-hexamethyleneimino; and     n is 2 or 3;  or a pharmaceutically acceptable salt thereof, comprising   a) condensing (C1-C4 alkyl) 4-hydroxybenzoate with ethylene carbonate or propylene carbonate in the presence of a condensation catalyst and a moderately polar, water immiscible solvent having a high boiling point;   b) reacting the product of step a), a compound of formula III <CHEM>  wherein     R and n are as defined above, with a leaving group donor; and   c) reacting the product of step b), a compound of formula IV <CHEM>  wherein     R and n are as defined above and X is a leaving group, with a base selected from the group consisting of piperidine, pyrrolidine, methylpyrrolidine, dimethylpyrrolidine, morpholine, dimethylamine, diethylamine, and 1-hexamethyleneimine.   The product of the above process, a compound of formula I, also is novel and is useful for the preparation of pharmaceutically active compounds of formula II, particularly via the following novel process   <CHEM>  wherein     R is C1-C4 alkyl; R<1> and R<2> each are independently C1-C4 alkyl, or combine to form piperidinyl, pyrrolidinyl, methylpyrrolidino, dimethylpyrrolidino, morpholino, dimethylamino, diethylamino, or 1-hexamethyleneimino; and     n is 2 or 3;  or a pharmaceutically acceptable salt thereof, comprising   a) condensing (C1-C4 alkyl) 4-hydroxybenzoate with ethylene carbonate or propylene carbonate in the presence of a condensation catalyst and a moderately polar, water immiscible solvent having a high boiling point;   b) reacting the product of step a), a compound of formula III <CHEM>  wherein     R and n are as defined above, with a leaving group donor;   c) reacting the product of step b), a compound of formula IV <CHEM>  wherein     R and n are as defined above; and X is a leaving group, with a base selected from the group consisting of piperidine, pyrrolidine, methylpyrrolidine, dimethylpyrrolidine, morpholine, dimethylamine, diethylamine, and 1-hexamethyleneimine;   d) reacting the product of step c) with a compound of formula IV <MATH> wherein R<3> and R<4> are as defined above, or a pharmaceutically acceptable salt thereof;   e) optionally removing the reaction product from step d) ; and f) optionally forming a salt of the reaction product from either step d) or step e).
Patent DE-69503273-D1 (DE)
Inventor: BAKER GERALD N
IPC: H02K5/24
Filed: 1995-02-16
Granted: 1998-08-13
Abstract: The switched reluctance motor (M) comprises a stator assembly (SA) including a stator (S) having a central bore (B) and a plurality of inwardly extending salient teeth (ST). A plurality of stator windings (W) are installed on the stator teeth. A rotor assembly (RA) includes a rotor mounted on a rotor shaft and installed in the central bore for rotation with respect to the stator assembly. The rotor assembly has a plurality of outwardly extending salient teeth (RT) with gaps (G) extending lengthwise of the rotor assembly between adjacent rotor teeth. A noise reducer assembly (10) installed on the rotor assembly reduces the noise produced by the rotor when the motor is operating at normal speeds. The assembly includes a lug (14) made of an electrically non-conducting material inserted in each rotor gap and extending lengthwise of the rotor assembly. Each lug is hollow with sidewalls (16A, 16B) and an inner endwall (16C) of all whose contours generally form mating contours with the respective sidewalls of the rotor teeth and the contour of the rotor at the inner end of a gap. An outer endwall (16D) of a lug has a curved contour the curvature of which generally corresponds to the curvature of the outer face of the rotor teeth. The lugs produce a surface between the outer faces of the adjacent rotor teeth which generally conforms to the outer surface (F) of the rotor teeth for the outer surface of the rotor assembly to be generally uniform thereabout. This helps reduce motor noise. The assembly also includes a cap (20) fitting over each end of the rotor assembly. The lugs are attached to the cap so to install the lugs on the rotor assembly. <IMAGE>   <IMAGE>
Patent DE-69509722-D1 (DE)
Inventor: HENDRIKS JAN
IPC: D21H17/29
Filed: 1995-09-12
Granted: 1999-06-24
Abstract: The invention relates to a method for manufacturing paper, which comprises adding to an aqueous suspension of cellulose fibers a water-soluble or dissolved cationic starch, optionally in addition to other additives, and then forming paper from this suspension in the conventional manner. The method according to the invention is characterized in that as cationic starch a cationic amylopectin potato starch is used. The invention also relates to paper so manufactured.
Patent DE-69521907-D1 (DE)
Inventor: NELSON CHRISTY
IPC: A61P35/00
Filed: 1995-11-22
Granted: 2001-08-30
Abstract: A compound of the structure   <IMAGE>   wherein R and R1 are each, independently,   <IMAGE>   or hydrogen; R2 and R3 are each, independently, alkyl, arylalkyl , or R2 and R3 may be taken together to form a cycloalkyl ring; R4 is a heterocyclic N-oxide radical, which may be optionally substituted; R5 is alkyl or arylalkyl; R6 and R7 are taken together to form a saturated N-alkyl-heterocyclic N-oxide, which may be optionally substituted; k=0-1, m=0-1; n=1-6; with the proviso that R and R1 are not both hydrogen, which is useful as an immunosuppressive, antiinflammatory, antifungal, antiproliferative, and antitumor agent.
Patent DE-69526413-D1 (DE)
Inventor: KOTANI TAKAYUKI
IPC: C07D233/74
Filed: 1995-12-20
Granted: 2002-05-23
Abstract: A compound is provided represented by the following general formula (A) <CHEM> wherein two of Ra, Rb and Rc are oxygen; X is a kind of benzyl, a kind of benzothiazolylmethyl, or a kind of naphthylmethyl; R is hydrogen or lower alkyl; n is an integer of 1 to 3; and Z indicates a direct bond or a bridging moiety containing one carbon atom. The compounds act as selective inhibitors of aldose reductase. The compounds provided are useful as drugs for therapy and prevention of various types of diabetic complications.